Neuvitan
C23H36N4O5S3 — CID 4582
View drug profile → octotiamineData last refreshed: (MolForge compound catalog, from PubChem)
About Neuvitan
Neuvitan (PubChem CID 4582) has the molecular formula C23H36N4O5S3 and a molecular weight of 544.77 g/mol. Its IUPAC name is methyl 6-acetylsulfanyl-8-[[2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-hydroxypent-2-en-3-yl]disulfanyl]octanoate.
Molecular Properties
| Compound Name | Neuvitan |
|---|---|
| PubChem CID | 4582 |
| Molecular Formula | C23H36N4O5S3 |
| Molecular Weight | 544.77 g/mol |
| Exact Mass | 544.18 |
| IUPAC Name | methyl 6-acetylsulfanyl-8-[[2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-hydroxypent-2-en-3-yl]disulfanyl]octanoate |
| SMILES | COC(=O)CCCCC(CCSSC(CCO)=C(C)N(C=O)Cc1cnc(C)nc1N)SC(C)=O |
| InChI | InChI=1S/C23H36N4O5S3/c1-16(27(15-29)14-19-13-25-17(2)26-23(19)24)21(9-11-28)35-33-12-10-20(34-18(3)30)7-5-6-8-22(31)32-4/h13,15,20,28H,5-12,14H2,1-4H3,(H2,24,25,26) |
| InChIKey | VJTXQHYNRDGLON-UHFFFAOYSA-N |
| XLogP | 4.09 |
| TPSA | 135.71 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 544.77 |
| LogP ≤ 5 | 4.09 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'disulphide', 'substructure': 'N/A'}, {'alert_name': 'thioester', 'substructure': 'N/A'} |
|---|
Related Compounds
Frequently Asked Questions
Browse: Molecules: N · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 4582 — identifiers, structure, computed properties (public domain)
- DrugCentral drug card 1979 — approved-drug record (CC BY-SA 4.0)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.